What drugs does WINDER LABS LLC make?

WINDER LABS LLC has 4 FDA-approved drugs including CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE.

What therapeutic areas does WINDER LABS LLC focus on?

WINDER LABS LLC focuses primarily on Immunology and Gastroenterology.

← Back

Data updated: Mar 10, 2026

WINDER LABS LLC

ImmunologyGastroenterology

Generics

WINDER LABS LLC is a generic drug manufacturer focused on Immunology, Gastroenterology.

2021

Since

Drugs

Trials

Approved (2yr)

Key Drugs

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE

chlordiazepoxide hydrochloride

4 indications · 2020

Recent Activity

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

MORPHINE SULFATE 2025-12-22

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%

1 drugs

Gastroenterology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Immunology, Gastroenterology

Bristol-Myers Squibb big-pharma

Immunology, Gastroenterology

BAUSCH specialty

Immunology, Gastroenterology

Takeda big-pharma

Immunology, Gastroenterology

Gilead Sciences biotech

Immunology, Gastroenterology

WINDER LABS LLC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (4)

Active (2)

Discontinued (2)

Company Info